96T
EKC34468
817 EUR
Verified reactivity:
Human
Verified applications:
ELISA
Protein number:
O75015
Tissue:
region
Shipping requirements:
Blue ice
Use for:
6 months
Assay duration:
1-5 hours
Research main area:
Immunology
Sensitivity limit:
0,39 ng/ml
ELISA detection:
Colorimetric
Assay class:
Please contact us
Estimated production time:
7-11 business days
Detection limits:
1.56 ng/ml-100 ng/ml
Gene number:
Please refer to GenBank
Alternate protein number:
Please refer to SwissProt
Samples to be analyzed:
serum, plasma, tissue homogenates
Assay principle:
Please see ELISA's datasheet, otherwise contact us
Precision of the test:
Please see ELISA's datasheet, otherwise contact us
ELISA's stability:
Please see ELISA's datasheet, otherwise contact us
Protocol:
Please see ELISA's datasheet, otherwise contact us
Notes:
For research use only. Not for diagnostic procedures.
Gene name:
Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
QC:
The kit is manufactured at ISO 9001 certified facilities.
ELISA's specificity:
To know the specificity of this test please feel free to contact us
ELISA's cross-reactivity:
This assay doesn't seem to cross-react with other species. For more information about cross-reactivity please contact us.
Alternate gene name:
CD16, CD16b, FCG3, FCGR3, Fc fragment of IgG, low affinity IIIb, receptor for (CD16) |Fc-gamma receptor IIIb (CD 16) |low affinity immunoglobulin gamma Fc region receptor III-B
Storage recommendation:
-20°C. Bring all reagents to room temperature before beginning test. The kit may be stored at 4°C for immediate use within two days upon arrival. Reseal any unused strips with desiccant pack. Minimize freeze/thaw cycles.
Test:
A high affinity purification column was use to purify immunoglobulin gamma Fc region receptor III-B (FCGR3B) ELISA Kit, 96 by bioma by chromatographic size exclusion.ELISA Enzyme-linked immunosorbent assays Code 90320007 SNOMED
Warnings:
The Stop Solution is acidic. Do not allow to contact skin or eyes. Calibrators, controls and specimen samples should be assayed in duplicate. Once the procedure has been started, all steps should be completed without interruption.
Properties:
E05 478 566 350 170 or Enzyme-Linked Immunosorbent Assays,E05 478 566 350 170 or Enzyme-Linked Immunosorbent Assays,Human proteins, cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies. Modern humans (Homo sapiens, primarily ssp. Homo sapiens sapiens). Depending on the epitopes used human ELISA kits can be cross reactive to many other species. Mainly analyzed are human serum, plasma, urine, saliva, human cell culture supernatants and biological samples.
Description:
A microtiter plate (spelled Microtiter is a registered trade name in the United States) or microplate or micro well plate or multiwell, is a flat plate with multiple "wells" used as small test tubes. The microplate has become a standard tool in analytical research and clinical diagnostic testing laboratories. A very common usage is in the enzyme-linked immunosorbent assay (ELISA), the basis of most modern medical diagnostic testing in humans and animals. A microplate typically has 6, 24, 96, 384 or 1536 sample wells arranged in a 23 rectangular matrix. Some microplates have even been manufactured with 3456 or 9600 wells, and an "array tape" product has been developed that provides a continuous strip of microplates embossed on a flexible plastic tape.The receptors are ligand binding factors of type 1, 2 or 3 and protein-molecules that receive chemical-signals from outside a cell. When such chemical-signals couple or bind to a receptor, they cause some form of cellular/tissue-response, e.g. a change in the electrical-activity of a cell. In this sense, am olfactory receptor is a protein-molecule that recognizes and responds to endogenous-chemical signals, chemokinesor cytokines e.g. an acetylcholine-receptor recognizes and responds to its endogenous-ligand, acetylcholine. However, sometimes in pharmacology, the term is also used to include other proteins that are drug-targets, such as enzymes, transporters and ion-channels.